Vium's digital platform, Digital Vivarium, combines computer vision, AI, machine learning, and sensor technology to collect and analyze non-invasive physiological metrics and behaviors. This enables researchers and drug developers to make better decisions on advancing compounds to the clinic, leading to more replicable studies and improved insights into disease progression. Vium is the first company to create a living informatics platform for preclinical in vivo drug research. With a wide range of customers, from biotech and pharmaceutical companies to academia and therapeutic labs, Vium is fully accredited by AAALAC International and has received commendation for upholding the gold-standard framework for humane animal research.